Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 215

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 215
---

out-of-pocket accountable expenses of no more than $200,000. In addition, we have agreed to pay Revere Securities LLC (“Revere”)
a $90,000 advisory fee, of which we have paid $40,000 with the remainder due upon the listing of our Class A Ordinary Shares on Nasdaq.
Any expenses advancement will be returned to us to the extent the underwriters’ out-of-pocket accountable expenses are not actually
incurred in accordance with FINRA Rule 5110(g)(4)(A).

We also agreed to pay to the Representative non-accountable
expenses equal to 1.0% of the gross proceeds raised in this offering.

Right of First Refusal

We have agreed to grant Revere, for a period
of twelve (12) months following the closing of this offering, a right of first refusal, exercisable at the sole discretion of the Revere,
to provide investment banking services to us on an exclusive basis for (a) acting as lead or joint-lead manager for any underwritten
public offering; (b) acting as lead or joint book runner and/or lead or joint placement agent, initial purchaser in connection with any
private offering of securities of the Company and (c) acting as financial advisor in connection with any sale or other transfer by the
Company, directly or indirectly, of a majority or controlling portion of its capital stock or assets to another entity, any purchase
or other transfer by another entity, directly or indirectly, of a majority or controlling portion of the capital stock or assets of the
Company, and any merger or consolidation of the Company with another entity. The right of first refusal shall be subject to FINRA Rule
5110(g)(5), including that it may be terminated by the Company for cause, which shall be a breach by Revere of its engagement letter
with the Company or a material failure by Revere to provide the services as contemplated by such engagement letter.

Lock-Up Agreements

We agreed that, subject to certain exceptions
set forth in the underwriting agreement/lock-up agreements, we will not, without the prior written consent of the Representative, from
the date of execution of the underwriting agreement and continuing for three (3) months from the closing date of this offering,
(i) offer, sell, or otherwise transfer or dispose of, directly or indirectly, any Class A Ordinary Shares of the Company or any
securities convertible into or exercisable or exchangeable for Class A Ordinary Shares of the Company; or (ii